Source: Huaxia Jingwei
Chen Shizhong is very high-end to find people with vaccine allergies. (Taiwan's "Zhongshi News Network" newspaper department data photo)
According to Taiwan's "Zhongshi News Network" report, Wang Renxian, chairman of the Taiwan Epidemic Prevention Society, called yesterday that the Taiwan authorities should prepare the BA.5 bivalent vaccine as soon as possible, especially the purchase of BNT times. Generation vaccines are intended for use by the youth population of the island. In response to this, the "epidemic command center" in Taiwan has not yet completed the contract with BNT, mainly because the other party has not submitted the information on the next-generation vaccines aged 5 to 11 to Taiwan's "Food and Drug Administration" for review, which is not intentional.
Wang Renxian said that ACIP had approved two bivalent vaccines of BA.4 and 5 as early as last month, but now it only recommends Modena, which has 4 times more side effects than BNT, for children over 6 years old. As for 5-6 At the age of 10, we plan to use the monovalent BNT vaccine to make these children completely orphans of the next generation. Zhuang Renxiang, a spokesman for the "epidemic command center" of
, responded today that since BNT has not yet submitted a document to the "Food and Drug Administration" to review the next-generation vaccine for children aged 5 to 11, it has not been possible to start the purchase. As for Modena, The complete data and documents have already been provided for review, so ACIP will make this decision, and it is by no means intentional about BNT.
In addition, the Taiwan Policy Foundation also questioned the high-end vaccines again, and asked the health authorities in Taiwan to take the initiative to disclose the contracts for high-end vaccines. Send a document to the high-end group to ask whether to agree to the public procurement contract. The
Taiwan Policy Foundation also pointed out that the Taiwan authorities should publish the details of adverse events of vaccination for the outside world to check the safety of vaccines of various brands. Zhuang Renxiang emphasized that the Adverse Drug Reaction Reporting Center of the "Food and Drug Administration" has public reports every week for external review. So far, the mortality rate of vaccine adverse events has not been seen to be higher than the background value. As for the disclosure of more detailed information, please ask "Food and Drug Administration" research. (Source: Huaxia Jingwei Network)
